Last reviewed · How we verify

NCT07273045: reGISTTry

A Comprehensive, Multinational GIST Registry

Not yet recruiting Last updated 9 December 2025
What this trial tests

trial in Gastrointenstinal Stromal Tumor (GIST) in 1,000 participants. Not yet recruiting.

Timeline
1 January 2026
Primary endpoint
1 January 2056
1 January 2056

Quick facts

Lead sponsorUniversität Duisburg-Essen
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 January 2026
Primary completion1 January 2056
Estimated completion1 January 2056
Sites1 location across Germany

Conditions studied

Sponsor

Universität Duisburg-Essen — full company profile →

Who can join

Eligibility, any sex, with Gastrointenstinal Stromal Tumor (GIST) or GIST - Gastrointestinal Stromal Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients diagnosed with a gastrointestinal stromal tumor (GIST), a rare type of tumor in the digestive tractparticipate in this scientific research study, known as a registry study, to help improve understanding and treatment of GIST. This study collects medical information and biological samples-such as blood or tumor tissue-from patients. It does not involve new treatments, medications, or medical procedures. The patient's regular medical care will continue as usual, and participation will not require extra appointments or tests. The study aims to learn more about how GIST behaves, especially in rare forms such as SDH-deficient or NF1-associated tumors. While targeted drugs are available for many patients, some tumors return or become resistant to treatment. By gathering data from many patients, researchers hope to better understand these challenges, identify risk factors for worse outcomes, and help design future studies and treatments-especially for rare types of GIST. If the patient agrees to participate, information will be collected from their medical records, scans (such as CT or MRI), and doctor visits. They may be asked to complete optional questionnaires about their health and quality of life. If they consent, small blood samples (up to 50 ml) may be collected during routine check-ups. If surgery is needed, a small part of the tumor tissue may be stored for research. Other samples-such as saliva, stool, urine, or spinal fluid-may also be collected if they are taken during normal care, to study how bacteria in the body might affect the disease and treatment. Participation is completely voluntary. The patient can choose to join or not, and can withdraw at any time without affecting their care or relationship with their doctor. Even if they do not agree to provide biological samples, they can still take part in the study by sharing medical data and scan results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastrointenstinal Stromal Tumor (GIST)

Currently open trials in the same condition.

Other Universität Duisburg-Essen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07273045.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing